TY - JOUR
T1 - Cut-off values of fasting and post-load plasma glucose and HbA 1c for predicting Type2 diabetes in community-dwelling Japanese subjects
T2 - The Hisayama Study
AU - Mukai, Naoko
AU - Doi, Y.
AU - Ninomiya, T.
AU - Hata, J.
AU - Hirakawa, Yoichiro
AU - Fukuhara, M.
AU - Iwase, M.
AU - Kiyohara, Y.
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2012/1
Y1 - 2012/1
N2 - Aims We examined the optimal cut-off values of fasting plasma glucose, 2-h post-load glucose and HbA 1c for predicting Type2 diabetes in community-dwelling Japanese subjects. Methods A total of 1982 subjects without diabetes aged 40-79years who underwent a 75-g oral glucose tolerance test were followed prospectively for 14years by annual health examination. Results During the follow-up, 295 subjects developed Type2 diabetes. Compared with the first decile, the crude hazard ratio for incident Type2 diabetes was significantly higher in the fifth fasting plasma glucose decile [5.4-5.4mmol/l (97-98mg/dl)] or higher, in the seventh 2-h post-load glucose decile [6.9-7.2mmol/l (124-131mg/dl)] or higher, and in the fifth HbA 1c decile [34-36 mmol/mol (5.3-5.4%)] or higher. These associations remained substantially unchanged even after adjustment for confounding factors. The receiver operating characteristic curve analysis showed that the optimal cut-off values for predicting Type2 diabetes were 5.6mmol/l (101mg/dl) for fasting plasma glucose, 6.9mmol/l (124mg/dl) for 2-h post-load glucose and 37mmol/mol (5.5%) for HbA 1c. In a stratified analysis, the cut-off values were approximately 5.6mmol/l (101mg/dl) for fasting plasma glucose and 37mmol/mol (5.5%) for HbA 1c, and these values were unchanged over BMI quartile levels, whereas the 2-h post-load glucose cut-off values declined with decreasing BMI levels. Conclusions Our findings suggest that the cut-off value for predicting Type2 diabetes in the Japanese population is 5.6mmol/l (101mg/dl) for fasting plasma glucose and 37mmol/mol (5.5%) for HbA 1c, while the 2-h post-load glucose cut-off value is lower than the diagnostic criterion for impaired glucose tolerance.
AB - Aims We examined the optimal cut-off values of fasting plasma glucose, 2-h post-load glucose and HbA 1c for predicting Type2 diabetes in community-dwelling Japanese subjects. Methods A total of 1982 subjects without diabetes aged 40-79years who underwent a 75-g oral glucose tolerance test were followed prospectively for 14years by annual health examination. Results During the follow-up, 295 subjects developed Type2 diabetes. Compared with the first decile, the crude hazard ratio for incident Type2 diabetes was significantly higher in the fifth fasting plasma glucose decile [5.4-5.4mmol/l (97-98mg/dl)] or higher, in the seventh 2-h post-load glucose decile [6.9-7.2mmol/l (124-131mg/dl)] or higher, and in the fifth HbA 1c decile [34-36 mmol/mol (5.3-5.4%)] or higher. These associations remained substantially unchanged even after adjustment for confounding factors. The receiver operating characteristic curve analysis showed that the optimal cut-off values for predicting Type2 diabetes were 5.6mmol/l (101mg/dl) for fasting plasma glucose, 6.9mmol/l (124mg/dl) for 2-h post-load glucose and 37mmol/mol (5.5%) for HbA 1c. In a stratified analysis, the cut-off values were approximately 5.6mmol/l (101mg/dl) for fasting plasma glucose and 37mmol/mol (5.5%) for HbA 1c, and these values were unchanged over BMI quartile levels, whereas the 2-h post-load glucose cut-off values declined with decreasing BMI levels. Conclusions Our findings suggest that the cut-off value for predicting Type2 diabetes in the Japanese population is 5.6mmol/l (101mg/dl) for fasting plasma glucose and 37mmol/mol (5.5%) for HbA 1c, while the 2-h post-load glucose cut-off value is lower than the diagnostic criterion for impaired glucose tolerance.
UR - http://www.scopus.com/inward/record.url?scp=83155182345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83155182345&partnerID=8YFLogxK
U2 - 10.1111/j.1464-5491.2011.03378.x
DO - 10.1111/j.1464-5491.2011.03378.x
M3 - Article
C2 - 21726278
AN - SCOPUS:83155182345
SN - 0742-3071
VL - 29
SP - 99
EP - 106
JO - Diabetic Medicine
JF - Diabetic Medicine
IS - 1
ER -